Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score

Table 3 Patients’ clinical characteristics and MSAS

	Complication		P-value
	No (n = 85)	Yes (n = 53)	P-value
Age (years)	44.1 (±10.1)	43.1 (±9.8)	0.51
BMI (kg/m²)	22.9 (±3.0)	22.9 (±3.3)	0.98
Underlying disease (n)	17 (20.0)	7 (13.2)	0.31
Previous pelvic surgery (n)	35 (41.2)	18 (33.7)	0.40
Surgical time (min)	190.0 (±70.9)	221.0 (±90.0)	0.026
Preoperative Hb (g/dL)	13.0 (±1.20)	12.6 (±1.3)	0.10
Postoperative Hb (g/dL)	12.8 (±1.3)	11.0 (±1.3)	0.27
NAC (n)	4 (4.7)	3 (5.8)	0.77
Surgical procedure (n)			0.47
Radical trachelectomy (±BPLD and PALND)	12 (14.1)	9 (17.0)
Radical hysterectomy (±BPLD, PALND, and BSO)	73 (85.9)	44 (83.0)
SAS	7.4 (±1.1)	7.1 (±1.3)	0.27
MSAS	7.0 (±1.2)	6.5 (±1.8)	0.047

MSAS modified surgical Apgar score, BMI body mass index, Hb hemoglobulin, NAC neoadjuvant chemotherapy, BPLD bilateral pelvic lymph node dissection, PALND paraaortic lymph node dissection, BSO bilateral salpingo-oophorectomy, SAS surgical Apgar score
Data are presented as means (± standard deviations) or as numbers of patients (%)

ISSN: 1471-2407